Global Harmonization Task Force, Study Groups 1 and 5; Proposed and Final Documents; Availability; Correction, 54600 [E8-22094]

Download as PDF 54600 Federal Register / Vol. 73, No. 184 / Monday, September 22, 2008 / Notices Dated: September 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–22040 Filed 9–19–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES Advisory Council for the Elimination of Tuberculosis Meeting (ACET) BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting. Times and Dates: 8:30 a.m.–5:30 p.m., October 7, 2008. 8:30 a.m.–2 p.m., October 8, 2008. Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, Telephone (404) 639– 8317. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to be Discussed: Agenda items include issues pertaining to update on nucleic acid amplification guidelines; update on interferon gamma release assays guidelines; update on the isolation guidelines; update on travel restrictions guidelines and other related tuberculosis issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, 1600 Clifton Road, NE., M/S E–07, Atlanta, Georgia 30333, Telephone (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Aug<31>2005 19:11 Sep 19, 2008 Jkt 214001 Food and Drug Administration [Docket No. FDA–2008–D–0372] Global Harmonization Task Force, Study Groups 1 and 5; Proposed and Final Documents; Availability; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of July 11, 2008 (73 FR 39968). The notice announced the availability of Global Harmonization Task Force documents entitled ‘‘Role of Standards’’ and ‘‘Clinical Investigations.’’ The notice was published with an incorrect document number. This document corrects that number. FOR FURTHER INFORMATION CONTACT: Paul Gadiock, Center for Devices and Radiological Health (HFZ–215), Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850, 240–276– 2343. SUMMARY: In FR Doc. E8–15797, appearing on page 39968 in the Federal Register of Friday, July 11, 2008, the following correction is made: 1. On page 39968, in the third column, in the third paragraph, in the 8th and 9th lines, ‘‘SG5(PD)/N37:2007’’ is corrected to read ‘‘SG5(PD)/ N3R7:2007.’’ SUPPLEMENTARY INFORMATION: Dated: September 11, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8–22094 Filed 9–19–08; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Biophysics of Neural Systems Study Section, October 2, 2008, PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 8 am to October 3, 2008, 5 pm, One Washington Circle Hotel, One Washington Circle, Washington, DC 20037 which was published in the Federal Register on September 9, 2008, 73 FR 52395–52397. The meeting will be held one day only October 2, 2008, from 8 am to 8 pm. The meeting location remains the same. The meeting is closed to the public. Dated: September 15, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–22055 Filed 9–19–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive And Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; R13 Conference Application. Date: October 23, 2008. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: D.G. Patel, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7682, pateldg@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Ancillary Study for PKD. Date: October 27, 2008. Time: 12 p.m. to 2 p.m. E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 73, Number 184 (Monday, September 22, 2008)]
[Notices]
[Page 54600]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22094]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2008-D-0372]


Global Harmonization Task Force, Study Groups 1 and 5; Proposed 
and Final Documents; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of July 11, 2008 (73 FR 39968). 
The notice announced the availability of Global Harmonization Task 
Force documents entitled ``Role of Standards'' and ``Clinical 
Investigations.'' The notice was published with an incorrect document 
number. This document corrects that number.

FOR FURTHER INFORMATION CONTACT: Paul Gadiock, Center for Devices and 
Radiological Health (HFZ-215), Food and Drug Administration, 1350 
Piccard Dr., Rockville, MD 20850, 240-276-2343.

SUPPLEMENTARY INFORMATION: In FR Doc. E8-15797, appearing on page 39968 
in the Federal Register of Friday, July 11, 2008, the following 
correction is made:
    1. On page 39968, in the third column, in the third paragraph, in 
the 8th and 9th lines, ``SG5(PD)/N37:2007'' is corrected to read 
``SG5(PD)/N3R7:2007.''

    Dated: September 11, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-22094 Filed 9-19-08; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.